# Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms

> **NCT01171014** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fonterra Research Centre** · enrollment: 100 (actual)

## Conditions studied

- Gastrointestinal Symptoms

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium lactis HN019
- **DIETARY_SUPPLEMENT:** Bifidobacterium lactis HN019
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01171014
- **Lead sponsor:** Fonterra Research Centre
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171014, "Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01171014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*